Mastodon

Normoflorin® D (Liquid) Instructions for Use

Marketing Authorization Holder

Bifilux, LLC (Russia)

Manufactured By

Bifilux+ SPC, LLC (Russia)

Contact Information

BIFILYUKS LLC (Russia)

Dosage Form

Bottle OTC Icon Normoflorin® D Oral liquid: bottle 100 ml

Dosage Form, Packaging, and Product Composition

Liquid for oral administration.

1 ml
Lactobacilli (Lactobacillus casei) Not less than 1×109 CFU
Bifidobacteria (Bifidobacterium bifidum, Bifidobacterium longum) Not less than 1×108 CFU

Auxiliary substances: bacterial metabolites (organic acids, amino acids (including essential ones), micro- and macroelements, vitamins, antimicrobial substances of natural origin).

Does not contain genetically modified microorganisms.

Nutritional Value 100 ml 30 ml (single adult dose)
Proteins 2% 0.5 g
Fats 0% 0 g
Carbohydrates 4% 1 g
Energy value 105 kJ/25 kcal 30 kJ/8 kcal
Potassium 4.58% 1.4 g
Calcium 4.2% 1.3 g
Magnesium 0.02 mg/kg 0.01 mg/kg

Does not contain lactose, cow’s milk protein, preservatives, colorants, taste adapters.

100 ml – glass bottles with a cap (1) – cardboard boxes.

Therapeutic Category

Dietary supplement – source of bifidobacteria and lactobacilli

Properties

It rapidly suppresses the activity of pathogenic microflora, prevents the penetration of endotoxins into the body; restores the protective biofilm on all mucous membranes, intestinal motility; reduces the level of cholesterol and oxalates; breaks down lactose.

Specially selected strains in the biocomplex have a pronounced immunomodulatory effect, reduce the risk of atopic dermatitis by stimulating the production of interferons and contribute to maintaining the general pool of immunoglobulins.

It has less pronounced acidity, which allows its use in treatment programs for acid-dependent diseases (peptic ulcer, erosive lesions of mucous membranes).

The microorganisms in the biocomplex are not genetically modified. Absence of lactose and cow’s milk protein. Completely natural, without preservatives, colorants, taste adapters.

Scope of Application

Of the product Normoflorin® D

As a dietary supplement – a source of probiotic microorganisms for

  • Chronic gastrointestinal diseases (gastritis, duodenitis, peptic ulcer, pancreatitis, cholecystitis, hepatitis, colitis, proctosigmoiditis) (as part of complex therapy);
  • Acute intestinal infections of established (shigellosis, salmonellosis, staphylococcal enterocolitis, enterovirus and rotavirus infection, etc.) and unknown etiology (as part of complex therapy);
  • Malabsorption syndrome, disaccharidase (lactase) deficiency, food allergy (as part of complex therapy);
  • Metabolic syndrome and obesity (as part of complex therapy);
  • For the restoration of disturbed microbiocenosis during antibacterial therapy;
  • For women during pregnancy and breastfeeding;
  • For allergic diseases and immunodeficiency states;
  • Antibiotic-associated diarrhea (including in children);
  • For increasing immunomodulatory and general strengthening activity.

ICD codes

ICD-10 code Indication
A02 Other salmonella infections
A03 Shigellosis
A04 Other bacterial intestinal infections
A04.7 Enterocolitis due to Clostridium difficile
A08.0 Rotaviral enteritis
A08.3 Other viral enteritis
A09 Other and unspecified gastroenteritis and colitis of infectious origin
D84.9 Immunodeficiency, unspecified
E63.8 Other specified types of nutritional deficiency
E66 Obesity
E73.0 Congenital lactase deficiency
E73.1 Secondary lactase deficiency
E88.8 Other specified metabolic disorders
K25 Gastric ulcer
K26 Duodenal ulcer
K29 Gastritis and duodenitis
K52 Other noninfectious gastroenteritis and colitis
K63.8 Other specified diseases of intestine
K73 Chronic hepatitis, not elsewhere classified
K81 Cholecystitis
K86.1 Other chronic pancreatitis
K90 Intestinal malabsorption
O99.6 Diseases of the digestive system complicating pregnancy, childbirth and the puerperium
T78.4 Allergy, unspecified
Y40 Systemically acting antibiotics
Z39.1 Care and examination of lactating mother
ICD-11 code Indication
1A01 Intestinal infection caused by other Vibrio species
1A02 Intestinal infections due to Shigella
1A03.Z Intestinal infections caused by Escherichia coli, unspecified
1A04 Intestinal infections caused by Clostridium difficile
1A09.Z Salmonella infection, unspecified
1A0Z Bacterial intestinal infections, unspecified
1A21 Gastroenteritis due to Astrovirus
1A22 Gastroenteritis due to Rotavirus
1A2Y Other specified viral intestinal infections
1A2Z Viral intestinal infections, unspecified
1A40.Z Infectious gastroenteritis or colitis, unspecified
1A9Y Other specified infections predominantly sexually transmitted
4A0Z Unspecified primary immunodeficiencies
4A8Z Allergic conditions or hypersensitivity conditions of unspecified type
5B7Z Malnutrition, unspecified
5B81.Z Obesity, unspecified
5C50.G Trimethylaminuria
5C53.1 Disorders of the citric acid cycle
5C53.2Z Disorders of mitochondrial oxidative phosphorylation, unspecified
5C53.3Z Disorders of mitochondrial membrane transport, unspecified
5C59.Z Congenital disorders of neurotransmitter metabolism, unspecified
5C61.61 Congenital lactase deficiency
5C61.62 Secondary lactase deficiency
5C63.Z Disorders of vitamin or nonprotein cofactor absorption or transport, unspecified
5D2Z Metabolic disorders, unspecified
8D40.0 Encephalopathy due to nutritional deficiency
DA42.81 Radiation gastritis
DA42.8Z Gastritis due to external causes, unspecified
DA42.Z Gastritis, unspecified
DA51.53 Radiation duodenitis
DA51.5Z Duodenitis due to external causes, unspecified
DA51.Z Duodenitis, unspecified
DA60.Z Gastric ulcer, unspecified
DA63.Z Duodenal ulcer, unspecified
DA7Z Diseases of stomach or duodenum, unspecified
DA92.1 Pneumatosis intestinalis of the small intestine
DA96.0Z Intestinal malabsorption, unspecified
DA98.Z Polyps of small intestine, unspecified
DB31.1 Pneumatosis of the colon
DB33.2Z Allergic or alimentary colitis, unspecified
DB33.4Y Other specified colitis or proctitis caused by external agents
DB33.4Z Colitis or proctitis caused by external agents, unspecified
DB36.Z Certain infections of the colon, unspecified
DB97.2 Chronic hepatitis, not elsewhere classified
DC12.Z Cholecystitis, unspecified
DC32.0 Calcific pancreatitis
DC32.1 Paraduodenal pancreatitis
DC32.2 Hereditary chronic pancreatitis
DC32.4 Chronic idiopathic pancreatitis
DC32.5 Tropical pancreatitis
DC32.Z Chronic pancreatitis, unspecified
DC33 Autoimmune pancreatitis
DE2Z Diseases of the digestive system, unspecified
JB64.6 Diseases of the digestive system complicating pregnancy, childbirth, or the puerperium
PL00 Drugs, medicaments or biological substances causing injury or harm in therapeutic use
QA48.1 Care or examination of a nursing mother
1A1Y Other specified bacterial foodborne intoxications
XN0SE Clostridium difficile

Dosage Regimen

The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen.

Orally, 30 minutes before meals, 1-2 times/day.

3-5 ml (0.5-1 tsp) 5-7 ml (1-1.5 tsp) 7-10 ml (0.5-1 tbsp) 10-15 ml (1-1.5 tbsp) 15-20 ml (1.5-2 tbsp) 20-30 ml (2-3 tbsp)
Prevention – at least 14 days

Shake before use and, if desired, dilute 1:2 or more with any food liquid at room temperature, consume immediately. Do not heat!

For increased acidity, it can be diluted with still, slightly alkaline mineral water.

Contraindications

  • Individual intolerance to the components.

Special Instructions

A dietary supplement. Is not a medicinal product.

Consultation with a doctor is recommended before use.

Use in Pediatrics

For children from 6 months to 14 years, the product should be taken in agreement with a pediatrician.

Drug Interactions

The product is compatible with any pharmaceutical preparations.

During antibacterial therapy, Normoflorin® D is prescribed from the first day of treatment, with an interval of 2-4 hours after taking the antibiotic.

Dispensing Status

Distributed through pharmacy networks and specialized departments of retail chains.

Storage Conditions

The product should be stored in a refrigerator, at a temperature of 4±2°C (35.6°F). When opened, store in a tightly closed bottle in the refrigerator.

Shelf Life

Shelf life – 60 days from the date of manufacture in an unopened factory package.

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.

Medical Disclaimer

TABLE OF CONTENTS